Free Trial
NASDAQ:XNCR

Xencor (XNCR) Stock Price, News & Analysis

Xencor logo
$7.23 -0.09 (-1.23%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$7.24 +0.00 (+0.07%)
As of 08/8/2025 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Xencor Stock (NASDAQ:XNCR)

Key Stats

Today's Range
$7.09
$7.60
50-Day Range
$7.23
$9.74
52-Week Range
$7.07
$27.24
Volume
872,504 shs
Average Volume
608,290 shs
Market Capitalization
$515.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.43
Consensus Rating
Moderate Buy

Company Overview

Xencor Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

XNCR MarketRank™: 

Xencor scored higher than 70% of companies evaluated by MarketBeat, and ranked 268th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Xencor has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 7 buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Xencor has only been the subject of 2 research reports in the past 90 days.

  • Read more about Xencor's stock forecast and price target.
  • Earnings Growth

    Earnings for Xencor are expected to grow in the coming year, from ($3.68) to ($3.64) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Xencor is -3.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Xencor is -3.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Xencor has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    12.32% of the outstanding shares of Xencor have been sold short.
  • Short Interest Ratio / Days to Cover

    Xencor has a short interest ratio ("days to cover") of 10.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Xencor has recently increased by 127,291.30%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Xencor does not currently pay a dividend.

  • Dividend Growth

    Xencor does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.32% of the outstanding shares of Xencor have been sold short.
  • Short Interest Ratio / Days to Cover

    Xencor has a short interest ratio ("days to cover") of 10.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Xencor has recently increased by 127,291.30%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Xencor has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Xencor this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Xencor insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $103,209.00 in company stock.

  • Percentage Held by Insiders

    Only 4.76% of the stock of Xencor is held by insiders.

  • Read more about Xencor's insider trading history.
Receive XNCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xencor and its competitors with MarketBeat's FREE daily newsletter.

XNCR Stock News Headlines

Xencor (XNCR) Q2 Revenue Jumps 82%
Xencor (NASDAQ:XNCR) Hits New 12-Month Low Following Analyst Downgrade
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Xencor price target lowered to $26 from $31 at Wedbush
Xencor (XNCR) to Release Earnings on Monday
Short Interest in Xencor, Inc. (NASDAQ:XNCR) Rises By 127,291.3%
Analysts Set Xencor, Inc. (NASDAQ:XNCR) Price Target at $28.00
See More Headlines

XNCR Stock Analysis - Frequently Asked Questions

Xencor's stock was trading at $22.98 at the beginning of the year. Since then, XNCR stock has decreased by 68.5% and is now trading at $7.23.

Xencor, Inc. (NASDAQ:XNCR) posted its earnings results on Wednesday, August, 6th. The biopharmaceutical company reported ($0.41) EPS for the quarter, topping analysts' consensus estimates of ($0.78) by $0.37. The business's revenue for the quarter was up 82.4% on a year-over-year basis.

Xencor's top institutional investors include Geode Capital Management LLC (2.39%), Aberdeen Group plc (0.79%), Essex LLC (0.15%) and Los Angeles Capital Management LLC (0.13%). Insiders that own company stock include Bassil I Dahiyat, John R Desjarlais, John J Kuch, Allen Yang, Nancy Valente, Celia Eckert, Alan Bruce Montgomery, Kurt A Gustafson, Richard J Ranieri and Ellen Feigal.
View institutional ownership trends
.

Shares of XNCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Xencor investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/06/2025
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:XNCR
CIK
1326732
Employees
280
Year Founded
N/A

Price Target and Rating

High Price Target
$34.00
Low Price Target
$6.00
Potential Upside/Downside
+265.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$232.62 million
Net Margins
-121.52%
Pretax Margin
-122.54%
Return on Equity
-25.75%
Return on Assets
-18.19%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.34
Quick Ratio
5.89

Sales & Book Value

Annual Sales
$110.49 million
Price / Sales
4.67
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.70 per share
Price / Book
0.83

Miscellaneous

Outstanding Shares
71,320,000
Free Float
67,783,000
Market Cap
$515.64 million
Optionable
Optionable
Beta
0.89

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:XNCR) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners